Overview Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect Status: COMPLETED Trial end date: 2022-05-17 Target enrollment: Participant gender: Summary One dose group of 0.004% was used.Phase: PHASE1 Details Lead Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.